Paid Clinical Trials Tampa

Discover 1,448 paid clinical trials in Tampa, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,448

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Tampa FL, Orlando FL, Jacksonville FL, Doral FLshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Asthma Research Study for Ages 12–17Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Seminole FL, Jacksonville FL, Miami FL, Destin FLshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

Olvimulogene Nanivacirepvec & Platinum-doubletEfficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Recruiting

PHASE2

Sponsor:

Genelux Corporation

Location:

Clermont FL, Orange City FL, Plantation FL, Miami FLshow 3 more

Code:

NCT06463665

Conditions

Advanced Non-squamous Non-small-cell Lung Cancer

Advanced Squamous Non-Small Cell Lung Carcinoma

Metastatic Non-squamous Non Small Cell Lung Cancer

Metastatic Squamous Non-Small Cell Lung Carcinoma

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Olvimulogene nanivacirepvec

Platinum chemotherapy: carboplatin or cisplatin

Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLC

Physician's Choice of Immune Checkpoint Inhibitor: pembrolizumab, nivolumab, cemiplimab, atezolizumab, durvalumab

Docetaxel

RLS-0071Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Recruiting

PHASE2

Sponsor:

ReAlta Life Sciences, Inc.

Location:

Saint Petersburg FL, Glen Burnie MD, Philadelphia PA, Omaha NE

Code:

NCT06175065

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

RLS-0071

Placebo

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Tampa FL, Brandon FL, Boca Raton FL, Tamarac FLshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

AF AblationObservational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Recruiting

Sponsor:

Kansas City Heart Rhythm Research Foundation

Location:

Sarasota FL, Jonesboro AR, Overland Park KS

Code:

NCT05826665

Conditions

Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Persistent AF ablation assisted with the STAR Apollo Mapping System

Harmony TPVHarmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Tampa FL, Charleston SC, Birmingham AL, Charlotte NCshow 17 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

New Port Richey FL, Clermont FL, Ocoee FL, Lady Lake FLshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

DFMOTargeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

Recruiting

PHASE1

PHASE2

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Tampa FL

Code:

NCT06219174

Conditions

Non Small Cell Lung Cancer

Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Difluoromethylornithine

LeuprolideStudy to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Recruiting

PHASE2

Sponsor:

Enteris BioPharma Inc.

Location:

Sarasota FL, Norfolk VA, Columbus OH, Seattle WA

Code:

NCT05096065

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

Leuprolide Oral Tablet - 120 mg - QD- Treatment A

Leuprolide Oral Tablet - 80 mg - QD - Treatment B

Leuprolide Oral Tablet - 60 mg - QD - Treatment C

Leuprolide Oral Tablet - 60 mg - BID - Treatment D

Leuprolide Oral Tablet - 40 mg - BID - Treatment E

Thoracotomy vs. ThoracoscopicThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Tampa FL, Saint Petersburg FL, Orlando FL, Fort Myers FLshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy